[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Aminoglycoside Antibiotics Market Report 2017

April 2017 | 103 pages | ID: U7635E76D35EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Aminoglycoside Antibiotics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Aminoglycoside Antibiotics in these regions, from 2012 to 2022 (forecast).
United States Aminoglycoside Antibiotics market competition by top manufacturers/players, with Aminoglycoside Antibiotics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Britannica
  • Novartis Pharmaceuticals
  • Merck
  • Kremoint Pharma
  • Medson Pharmaceuticals
  • Allergan
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Kanamycin
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Aminoglycoside Antibiotics for each application, including
  • Veterinary
  • Respiratory
  • UTI & Pelvic Disease
  • Neonatal Sepsis
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Aminoglycoside Antibiotics Market Report 2017

1 AMINOGLYCOSIDE ANTIBIOTICS OVERVIEW

1.1 Product Overview and Scope of Aminoglycoside Antibiotics
1.2 Classification of Aminoglycoside Antibiotics by Product Category
  1.2.1 United States Aminoglycoside Antibiotics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Aminoglycoside Antibiotics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Neomycin
  1.2.4 Tobramycin
  1.2.5 Gentamicin
  1.2.6 Amikacin
  1.2.7 Paromomycin
  1.2.8 Kanamycin
1.3 United States Aminoglycoside Antibiotics Market by Application/End Users
  1.3.1 United States Aminoglycoside Antibiotics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Veterinary
  1.3.3 Respiratory
  1.3.4 UTI & Pelvic Disease
  1.3.5 Neonatal Sepsis
1.4 United States Aminoglycoside Antibiotics Market by Region
  1.4.1 United States Aminoglycoside Antibiotics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Aminoglycoside Antibiotics Status and Prospect (2012-2022)
  1.4.3 Southwest Aminoglycoside Antibiotics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Aminoglycoside Antibiotics Status and Prospect (2012-2022)
  1.4.5 New England Aminoglycoside Antibiotics Status and Prospect (2012-2022)
  1.4.6 The South Aminoglycoside Antibiotics Status and Prospect (2012-2022)
  1.4.7 The Midwest Aminoglycoside Antibiotics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Aminoglycoside Antibiotics (2012-2022)
  1.5.1 United States Aminoglycoside Antibiotics Sales and Growth Rate (2012-2022)
  1.5.2 United States Aminoglycoside Antibiotics Revenue and Growth Rate (2012-2022)

2 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Aminoglycoside Antibiotics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Aminoglycoside Antibiotics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Aminoglycoside Antibiotics Average Price by Players/Suppliers (2012-2017)
2.4 United States Aminoglycoside Antibiotics Market Competitive Situation and Trends
  2.4.1 United States Aminoglycoside Antibiotics Market Concentration Rate
  2.4.2 United States Aminoglycoside Antibiotics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Aminoglycoside Antibiotics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Aminoglycoside Antibiotics Sales and Market Share by Region (2012-2017)
3.2 United States Aminoglycoside Antibiotics Revenue and Market Share by Region (2012-2017)
3.3 United States Aminoglycoside Antibiotics Price by Region (2012-2017)

4 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Aminoglycoside Antibiotics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Aminoglycoside Antibiotics Revenue and Market Share by Type (2012-2017)
4.3 United States Aminoglycoside Antibiotics Price by Type (2012-2017)
4.4 United States Aminoglycoside Antibiotics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Aminoglycoside Antibiotics Sales and Market Share by Application (2012-2017)
5.2 United States Aminoglycoside Antibiotics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Britannica
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Britannica Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis Pharmaceuticals
  6.2.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Kremoint Pharma
  6.4.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Kremoint Pharma Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Medson Pharmaceuticals
  6.5.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Medson Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.2 Aminoglycoside Antibiotics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Aminoglycoside Antibiotics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 AMINOGLYCOSIDE ANTIBIOTICS MANUFACTURING COST ANALYSIS

7.1 Aminoglycoside Antibiotics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Aminoglycoside Antibiotics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Aminoglycoside Antibiotics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Aminoglycoside Antibiotics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AMINOGLYCOSIDE ANTIBIOTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Aminoglycoside Antibiotics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Aminoglycoside Antibiotics Sales Volume Forecast by Type (2017-2022)
11.3 United States Aminoglycoside Antibiotics Sales Volume Forecast by Application (2017-2022)
11.4 United States Aminoglycoside Antibiotics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Aminoglycoside Antibiotics
Figure United States Aminoglycoside Antibiotics Market Size (K Units) by Type (2012-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume Market Share by Type (Product Category) in 2016
Figure Neomycin Product Picture
Figure Tobramycin Product Picture
Figure Gentamicin Product Picture
Figure Amikacin Product Picture
Figure Paromomycin Product Picture
Figure Kanamycin Product Picture
Figure United States Aminoglycoside Antibiotics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Aminoglycoside Antibiotics by Application in 2016
Figure Veterinary Examples
Figure Respiratory Examples
Figure UTI & Pelvic Disease Examples
Figure Neonatal Sepsis Examples
Figure United States Aminoglycoside Antibiotics Market Size (Million USD) by Region (2012-2022)
Figure The West Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Aminoglycoside Antibiotics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Aminoglycoside Antibiotics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Aminoglycoside Antibiotics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Aminoglycoside Antibiotics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Aminoglycoside Antibiotics Sales Share by Players/Suppliers
Figure 2017 United States Aminoglycoside Antibiotics Sales Share by Players/Suppliers
Figure United States Aminoglycoside Antibiotics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Aminoglycoside Antibiotics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Aminoglycoside Antibiotics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Aminoglycoside Antibiotics Revenue Share by Players/Suppliers
Figure 2017 United States Aminoglycoside Antibiotics Revenue Share by Players/Suppliers
Table United States Market Aminoglycoside Antibiotics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Aminoglycoside Antibiotics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Aminoglycoside Antibiotics Market Share of Top 3 Players/Suppliers
Figure United States Aminoglycoside Antibiotics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Aminoglycoside Antibiotics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Aminoglycoside Antibiotics Product Category
Table United States Aminoglycoside Antibiotics Sales (K Units) by Region (2012-2017)
Table United States Aminoglycoside Antibiotics Sales Share by Region (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Share by Region (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Market Share by Region in 2016
Table United States Aminoglycoside Antibiotics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Aminoglycoside Antibiotics Revenue Share by Region (2012-2017)
Figure United States Aminoglycoside Antibiotics Revenue Market Share by Region (2012-2017)
Figure United States Aminoglycoside Antibiotics Revenue Market Share by Region in 2016
Table United States Aminoglycoside Antibiotics Price (USD/Unit) by Region (2012-2017)
Table United States Aminoglycoside Antibiotics Sales (K Units) by Type (2012-2017)
Table United States Aminoglycoside Antibiotics Sales Share by Type (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Share by Type (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Market Share by Type in 2016
Table United States Aminoglycoside Antibiotics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Aminoglycoside Antibiotics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Aminoglycoside Antibiotics by Type (2012-2017)
Figure Revenue Market Share of Aminoglycoside Antibiotics by Type in 2016
Table United States Aminoglycoside Antibiotics Price (USD/Unit) by Types (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Growth Rate by Type (2012-2017)
Table United States Aminoglycoside Antibiotics Sales (K Units) by Application (2012-2017)
Table United States Aminoglycoside Antibiotics Sales Market Share by Application (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Market Share by Application (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Market Share by Application in 2016
Table United States Aminoglycoside Antibiotics Sales Growth Rate by Application (2012-2017)
Figure United States Aminoglycoside Antibiotics Sales Growth Rate by Application (2012-2017)
Table Britannica Basic Information List
Table Britannica Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Britannica Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Britannica Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Britannica Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Novartis Pharmaceuticals Basic Information List
Table Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Novartis Pharmaceuticals Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Merck Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Merck Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Kremoint Pharma Basic Information List
Table Kremoint Pharma Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kremoint Pharma Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Kremoint Pharma Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Kremoint Pharma Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Medson Pharmaceuticals Basic Information List
Table Medson Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medson Pharmaceuticals Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Medson Pharmaceuticals Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Medson Pharmaceuticals Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Aminoglycoside Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Aminoglycoside Antibiotics Sales Growth Rate (2012-2017)
Figure Allergan Aminoglycoside Antibiotics Sales Market Share in United States (2012-2017)
Figure Allergan Aminoglycoside Antibiotics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Aminoglycoside Antibiotics
Figure Manufacturing Process Analysis of Aminoglycoside Antibiotics
Figure Aminoglycoside Antibiotics Industrial Chain Analysis
Table Raw Materials Sources of Aminoglycoside Antibiotics Major Players/Suppliers in 2016
Table Major Buyers of Aminoglycoside Antibiotics
Table Distributors/Traders List
Figure United States Aminoglycoside Antibiotics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Aminoglycoside Antibiotics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Aminoglycoside Antibiotics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Type in 2022
Table United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Application in 2022
Table United States Aminoglycoside Antibiotics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Aminoglycoside Antibiotics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Aminoglycoside Antibiotics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories